about
Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes.Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimentaPreclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.GM-CSF as a therapeutic target in inflammatory diseases.The Molecular Control of Regulatory T Cell Induction.Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients.Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus.CCR7 Modulates the Generation of Thymic Regulatory T Cells by Altering the Composition of the Thymic Dendritic Cell Compartment.Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice.Transgenic expression of GM-CSF in T cells causes disseminated histiocytosis.Lpr-induced systemic autoimmunity is unaffected by mast cell deficiency.Interleukin-6 modulates production of T lymphocyte–derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesisDifferentiation of Inflammatory Dendritic Cells Is Mediated by NF- B1-Dependent GM-CSF Production in CD4 T CellsBcl-2 overexpression ameliorates immune complex-mediated arthritis by altering FcγRIIb expression and monocyte homeostasisEvaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritisSoluble Fas levels in sera of bone marrow transplantation recipients are increased during acute graft-versus-host disease but not during infectionsA robust pipeline with high replication rate for detection of somatic variants in the adaptive immune system as a source of common genetic variation in autoimmune disease
P50
Q34522666-6B27199D-6A19-4EF0-80F6-A3B52643C983Q35834491-E40C17CA-DCF5-4434-962A-0FB1C75CAF65Q36150157-4E9F74C9-2AA9-4262-B892-0085E78033FFQ37388766-9713DAC4-118B-4887-AC20-F21852FFD004Q38101877-C2F145D5-3DA4-4549-9A4E-A35A9C48534BQ38128130-193A81D2-2CCC-40A0-8063-491F07C015DCQ38651636-BE7D11C2-9D1E-4E2B-B529-8852B17818B6Q38742750-B1E6C1C2-50AF-44E2-835D-F18AB75B9BBCQ41956989-01E5A5B9-83A9-424D-A5D4-625EEB8CDE1DQ42255910-A1E702E3-B883-4F20-8FA5-C5CC8F4B5F74Q47697144-7425A090-0B2F-46A6-B487-1A14ED027DF0Q48339231-ED64A459-7BE6-4417-B7F6-2EEB6F3F0481Q53084498-6DAC6E3D-D18D-4F20-AFE4-63E5FBBAA8C5Q55061885-09A57216-83CD-446E-90F1-C3F0935317FAQ57265520-E3A40D1A-49EA-439E-9333-BBAF4603DDC6Q58757842-503EBAD1-BA30-4528-A6AA-A415EB71151EQ62817652-21C0BC05-53BA-4304-907A-436EAABDEA6FQ62820055-BB73ABBC-8F4A-4C39-A561-FBB31291821CQ74138254-F050FF85-C2F0-48C0-BEB3-EE2A2EA90E2DQ90429228-0DDF068D-2A3E-43C4-B671-467BC0B2E215
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Annemarie van Nieuwenhuijze
@ast
Annemarie van Nieuwenhuijze
@en
Annemarie van Nieuwenhuijze
@es
Annemarie van Nieuwenhuijze
@nl
type
label
Annemarie van Nieuwenhuijze
@ast
Annemarie van Nieuwenhuijze
@en
Annemarie van Nieuwenhuijze
@es
Annemarie van Nieuwenhuijze
@nl
prefLabel
Annemarie van Nieuwenhuijze
@ast
Annemarie van Nieuwenhuijze
@en
Annemarie van Nieuwenhuijze
@es
Annemarie van Nieuwenhuijze
@nl
P106
P31
P496
0000-0001-8576-7523